首页> 外文OA文献 >Chymase-Dependent Generation of Angiotensin II from Angiotensin-(1-12) in Human Atrial Tissue
【2h】

Chymase-Dependent Generation of Angiotensin II from Angiotensin-(1-12) in Human Atrial Tissue

机译:人房组织中血管紧张素-(1-12)的血管紧张素II的酶依赖依赖性产生。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Since angiotensin-(1-12) [Ang-(1-12)] is a non-renin dependent alternate precursor for the generation of cardiac Ang peptides in rat tissue, we investigated the metabolism of Ang-(1-12) by plasma membranes (PM) isolated from human atrial appendage tissue from nine patients undergoing cardiac surgery for primary control of atrial fibrillation (MAZE surgical procedure). PM was incubated with highly purified 125I-Ang-(1-12) at 37°C for 1 h with or without renin-angiotensin system (RAS) inhibitors [lisinopril for angiotensin converting enzyme (ACE), SCH39370 for neprilysin (NEP), MLN-4760 for ACE2 and chymostatin for chymase; 50 µM each]. 125I-Ang peptide fractions were identified by HPLC coupled to an inline γ-detector. In the absence of all RAS inhibitor, 125I-Ang-(1-12) was converted into Ang I (2±2%), Ang II (69±21%), Ang-(1-7) (5±2%), and Ang-(1-4) (2±1%). In the absence of all RAS inhibitor, only 22±10% of 125I-Ang-(1-12) was unmetabolized, whereas, in the presence of the all RAS inhibitors, 98±7% of 125I-Ang-(1-12) remained intact. The relative contribution of selective inhibition of ACE and chymase enzyme showed that 125I-Ang-(1-12) was primarily converted into Ang II (65±18%) by chymase while its hydrolysis into Ang II by ACE was significantly lower or undetectable. The activity of individual enzyme was calculated based on the amount of Ang II formation. These results showed very high chymase-mediated Ang II formation (28±3.1 fmol×min−1×mg−1, n = 9) from 125I-Ang-(1-12) and very low or undetectable Ang II formation by ACE (1.1±0.2 fmol×min−1×mg−1). Paralleling these findings, these tissues showed significant content of chymase protein that by immunocytochemistry were primarily localized in atrial cardiac myocytes. In conclusion, we demonstrate for the first time in human cardiac tissue a dominant role of cardiac chymase in the formation of Ang II from Ang-(1-12).
机译:由于血管紧张素-(1-12)[Ang-(1-12)]是大鼠组织中产生心脏Ang肽的非肾素依赖性替代前体,因此我们通过血浆研究了Ang-(1-12)的代谢从9例接受心脏外科手术的患者的人心耳附件组织分离的膜(PM),以初步控制房颤(MAZE外科手术)。将PM与高度纯化的125I-Ang-(1-12)在37°C下孵育1小时,加入或不加入肾素-血管紧张素系统(RAS)抑制剂[赖诺普利用于血管紧张素转化酶(ACE),SCH39370用于中性溶酶(NEP), ACEN为MLN-4760,糜蛋白酶为促凝抑素;每个50 µM]。通过与在线γ-检测器偶联的HPLC鉴定125 I-Ang肽级分。在没有所有RAS抑制剂的情况下,125I-Ang-(1-12)转化为Ang I(2±2%),Ang II(69±21%),Ang-(1-7)(5±2%) )和Ang-(1-4)(2±1%)。在没有所有RAS抑制剂的情况下,只有22±10%的125I-Ang-(1-12)未被代谢,而在所有RAS抑制剂的存在下,125I-Ang-(1-12)的98±7% )保持原样。选择性抑制ACE和糜酶的相对贡献表明,糜酶主要将125I-Ang-(1-12)转化为Ang II(65±18%),而由ACE水解成Ang II的酶明显较低或无法检测到。基于Ang II形成的量计算单个酶的活性。这些结果表明,由125I-Ang-(1-12)产生的糜蛋白酶介导的Ang II形成非常高(28±3.1 fmol×min-1×mg-1,n = 9),而由ACE形成的Ang II的形成非常低或无法检测到( 1.1±0.2 fmol×min-1×mg-1)。与这些发现平行的是,这些组织显示出糜酶蛋白的大量含量,而糜酶蛋白的含量主要通过免疫细胞化学定位在心房心肌细胞中。总而言之,我们首次证明了人类糜酶在Ang-(1-12)Ang II形成中的心脏糜酶的主要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号